Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionOne Capital Management, LLC
Latest Disclosed Ownership5,067 shares
Latest Disclosed Value $ 706,255
One Capital Management, LLC reports 1.00% increase in ownership of GILD / Gilead Sciences, Inc.

On May 12, 2026 - One Capital Management, LLC filed a 13F-HR form disclosing ownership of 5,067 shares of Gilead Sciences, Inc. (CH:GILD) valued at $706,255 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 5,017 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Gilead Sciences COM 375558103 5,067 50 1.00 706 14.80 0.0193
2026-02-10 2025-12-31 13F Gilead Sciences COM 375558103 5,017 -73 -1.43 616 8.85 0.0186
2025-11-14 2025-09-30 13F Gilead Sciences COM 375558103 5,090 12 0.24 565 0.36 0.0180
2025-08-11 2025-06-30 13F Gilead Sciences COM 375558103 5,078 98 1.97 563 0.90 0.0195
2025-05-14 2025-03-31 13F Gilead Sciences COM 375558103 4,980 -826 -14.23 558 4.10 0.0189
2025-02-06 2024-12-31 13F GILEAD SCIENCES COM 375558103 5,806 6 0.10 536 10.29 0.0177
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 5,800 0 0.00 486 22.42 0.0155
2024-08-09 2024-06-30 13F GILEAD SCIENCES COM 375558103 5,800 1,560 36.79 398 28.06 0.0136
2024-05-08 2024-03-31 13F GILEAD SCIENCES COM 375558103 4,240 -1,601 -27.41 311 -34.46 0.0113
2024-02-07 2023-12-31 13F GILEAD SCIENCES COM 375558103 5,841 -1,693 -22.47 473 -16.13 0.0187
2023-11-09 2023-09-30 13F GILEAD SCIENCES COM 375558103 7,534 7,534 565 0.0251
2018-01-26 2017-12-31 13F GILEAD SCIENCES COM 375558103 0 -33,274 -100.00 0 -100.00
2017-11-02 2017-09-30 13F GILEAD SCIENCES COM 375558103 33,274 4,621 16.13 2,696 32.94 0.5608
2017-08-04 2017-06-30 13F GILEAD SCIENCES COM 375558103 28,653 2,794 10.80 2,028 15.49 0.5956
2017-05-01 2017-03-31 13F GILEAD SCIENCES COM 375558103 25,859 1,524 6.26 1,756 0.75 0.5460
2017-02-14 2016-12-31 13F GILEAD SCIENCES COM 375558103 24,335 -3 -0.01 1,743 -9.50 0.5533
2016-10-12 2016-09-30 13F GILEAD SCIENCES COMMON STOCK 375558103 24,338 24,338 1,926 0.6281
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.